WARF: P100188US01

  • Assigned to WARF as biological material.

Mouse Model for Mania


Stephen Gammie

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in a mouse model to understand the genetic and neurobiological basis of mania and aid in the development of new anti-mania drugs.
OVERVIEWPresently, there are no good rodent models for mania, which is a critical component of bipolar disorder. The most commonly used approach is to inject normal mice with amphetamines to produce hyperactivity. Many researchers feel these drug-induced traits do not model true mania.
THE INVENTIONA UW–Madison researcher has developed a novel line of mice which exhibit at least four characteristics of mania: hyperactivity, elevated aggression, increased risk taking and decreased sleep.

The line of mice originally was derived from outbred hsd:ICR mice as part of a study of high wheel-running. The researcher now has found that the mice exhibit mania behaviors like decreased daytime sleep and cage hyperactivity. Furthermore, some of these behaviors were tempered following treatment with the common anti-mania drugs valproate and olanzapine, as well as lithium.
  • Mouse model for research and drug development/testing
  • Model provides a new avenue for understanding the genetics and neurobiology of mania.
For More Information About the Inventors
  • Saul M.C., Gessay G.M. and Gammie S.C. 2012. A New Mouse Model for Mania Shares Genetic Correlates with Human Bipolar Disorder. PLoS One. 7, e38128.
Contact Information
For current licensing status, please contact Jennifer Gottwald at or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.